Back to Stock Dashboard
Sector:
Consumer Defensive
Add to portfolio
XAGE
Longevity Health Holdings, Inc.
CAPPED RATING
Longevity Health Holdings, Inc. (XAGE) is rated C (2.4/5) on Deltasharpe Prism, scored against Consumer Defensive sector peers. Its strongest pillar is Profitability (B); its weakest is Momentum (D).
Quantitative Factor Evaluation • Updated
Overall Rating
2.4
/ 5.0
C
Value
B-
Factor Score
3.0
/ 5.0
Growth
C
Factor Score
2.2
/ 5.0
Profitability
B
Factor Score
3.3
/ 5.0
Momentum
D
Factor Score
1.4
/ 5.0
Revisions
C-
Factor Score
2.0
/ 5.0
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
P/E Ratio
0.0
EV / EBITDA
0.0
Rev Growth YoY
-23.2%
Gross Margin
67.7%
Price Return 3M
-27.7%
Price Return 12M
-92.3%
Catalyst Signal
0.00
Market Cap
N/A
TTM Revenue
N/A
Price / Sales
0.3
ROE
0.0%
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-08-03 | B- (3.0) | C (2.2) | B (3.3) | D (1.4) | C- (2.0) | C (2.4) |